Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

NRx Pharmaceuticals, Inc. NRXP

Full chart Compare
Set alert

Price alert · NRXP

All alert types
2.24 USD +0.07 (+3.23%)

At closeNov 3, 2026, 7:44 PM EST

2.25 +0.01 +0.47%

After hours · Nov 3, 7:44 PM ET

2.11 Day range 2.34
1.62 52-week range 5.06
YTD
-17.34%
1 year
-21.40%

Financial health

Altman Z-Score

-13.84 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -2.0×
FY 2017: -807×FY 2018: 1377×FY 2019: 133×FY 2020: -162×FY 2021: -6.4×FY 2022: -18.5×FY 2023: -1.2×FY 2024: -0.9×FY 2025: -2.0×
FY 2017 5y median -2.0× FY 2025
P/S 47.3×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 47.3×
FY 2017 5y median 0.0× FY 2025
P/B -3.6×
FY 2017: 1.3×FY 2018: 1.3×FY 2019: 1.8×FY 2020: -3.0×FY 2021: 108×FY 2022: 98.5×FY 2023: -3.0×FY 2024: -1.0×FY 2025: -3.6×
FY 2017 5y median -1.0× FY 2025
P/FCF -4.1×
FY 2017: -644×FY 2018: -192×FY 2019: -68.0×FY 2020: -58.8×FY 2021: -59.5×FY 2022: -18.4×FY 2023: -1.6×FY 2024: -2.2×FY 2025: -4.1×
FY 2017 5y median -4.1× FY 2025
EV/EBITDA -1.8×
FY 2017: -829×FY 2018: 1113×FY 2019: 113×FY 2020: -2.6×FY 2021: -23.8×FY 2022: -18.1×FY 2023: -1.3×FY 2024: -1.2×FY 2025: -1.8×
FY 2017 5y median -1.8× FY 2025
EV/Sales 41.5×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 41.5×
FY 2017 5y median 0.0× FY 2025
FCF Yield -24.3%
FY 2017: -0.2%FY 2018: -0.5%FY 2019: -1.5%FY 2020: -1.7%FY 2021: -1.7%FY 2022: -5.4%FY 2023: -62.2%FY 2024: -46.0%FY 2025: -24.3%
FY 2017 5y median -24.3% FY 2025

Profitability

Gross Margin 58.8%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 58.8%
FY 2017 5y median 0.0% FY 2025
Operating Margin -1324.4%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -1324.4%
FY 2017 5y median 0.0% FY 2025
Net Margin -2336.5%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -2336.5%
FY 2017 5y median 0.0% FY 2025
ROE 179.6%
FY 2017: -0.2%FY 2018: 0.1%FY 2019: 1.4%FY 2020: 118.3%FY 2021: -447.3%FY 2022: -536.6%FY 2023: 257.0%FY 2024: 108.2%FY 2025: 179.6%
FY 2017 5y median 108.2% FY 2025
ROIC 106.0%
FY 2017: 0.0%FY 2018: -1.1%FY 2019: -1.9%FY 2020: 51.3%FY 2021: -446.5%FY 2022: -247.2%FY 2023: 1072.6%FY 2024: 118.4%FY 2025: 106.0%
FY 2017 5y median 106.0% FY 2025
ROA -220.9%
FY 2017: -0.2%FY 2018: 0.1%FY 2019: 1.3%FY 2020: -1760.5%FY 2021: -284.3%FY 2022: -154.0%FY 2023: -412.2%FY 2024: -688.2%FY 2025: -220.9%
FY 2017 5y median -284.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income 17.7%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 29.1%FY 2020: -2993.3%FY 2021: -331.5%FY 2022: 53.4%FY 2023: 37.8%FY 2024: 28.6%FY 2025: 17.7%
FY 2017 FY 2025
EPS (diluted) 43.9%
FY 2017: 0.0%FY 2018: 161.8%FY 2019: 979.6%FY 2020: -288.8%FY 2021: -392.7%FY 2022: 91.9%FY 2023: -563.3%FY 2024: 39.9%FY 2025: 43.9%
FY 2017 FY 2025
Free Cash Flow -32.7%
FY 2017: 0.0%FY 2018: -248.4%FY 2019: -67.5%FY 2020: -186.0%FY 2021: -1563.4%FY 2022: -5.4%FY 2023: 45.5%FY 2024: 50.9%FY 2025: -32.7%
FY 2017 FY 2025

Financial Health

Current Ratio 0.3×
FY 2017: 5.8×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 2.7×FY 2022: 1.7×FY 2023: 0.4×FY 2024: 0.2×FY 2025: 0.3×
FY 2017 5y median 0.4× FY 2025
Quick Ratio 0.3×
FY 2017: 5.8×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 2.7×FY 2022: 1.7×FY 2023: 0.4×FY 2024: 0.2×FY 2025: 0.3×
FY 2017 5y median 0.4× FY 2025
Debt / Equity -0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: -0.0×FY 2021: 0.0×FY 2022: 1.4×FY 2023: -0.8×FY 2024: -0.3×FY 2025: -0.0×
FY 2017 5y median -0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2017: 4.3×FY 2018: 8.2×FY 2019: 4.0×FY 2020: 0.0×FY 2021: 0.3×FY 2022: 0.2×FY 2023: -0.2×FY 2024: -0.2×FY 2025: 0.3×
FY 2017 5y median 0.2× FY 2025
Interest Coverage -24.2×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -394×FY 2021: -5289×FY 2022: 0.0×FY 2023: -230×FY 2024: -18.3×FY 2025: -24.2×
FY 2017 5y median -24.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31